Interspinous process decompression

Worldwide Interspinous Spacers Industry to 2029 - Static Spacers for Lumbar Spinal Stenosis Treatment to Drive Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 12, 2022
Medical Devices, Health, LSS, Ageing, Bleeding, Adoption, Spinal canal, Lumbar spinal stenosis, Population, Decompression, Research, Medtronic, Interspinous process decompression, Birth, Patient, Infection, Growth, Surgeon, NuVasive, Prevalence, Laminectomy, Risk, Pet, Antibiotics, Semiconductor

The global interspinous spacers market is segmented on the basis of product types, applications and geographical demarcation.

Key Points: 
  • The global interspinous spacers market is segmented on the basis of product types, applications and geographical demarcation.
  • Based on products, the static (compressible) spacers dominate the global market and shall retain its lead through the forecast period.
  • Evidence suggest that static interspinous spacers are the most cost-effective as against laminectomy in patients with lumbar spinal stenosis.
  • Among the applications, lumbar spinal stenosis (LSS) is the most prominent area experiencing the largest adoption of interspinous spacers.

Vertos Medical Announces ASC Reimbursement Increase for the mild® Procedure

Retrieved on: 
Tuesday, December 8, 2020
Medical specialties, Medicine, Geriatrics, Spinal cord disorders, Branches of biology, Vertos Medical, Lumbar spinal stenosis, Stenosis, Spinal stenosis, LSS, Interspinous process decompression

Effective January 1, 2021, the national average ASC reimbursement for CPT 0275T will increase by 41%, from $2,803.35 to $3,941.14, in recognition of the device cost associated with the procedure.

Key Points: 
  • Effective January 1, 2021, the national average ASC reimbursement for CPT 0275T will increase by 41%, from $2,803.35 to $3,941.14, in recognition of the device cost associated with the procedure.
  • "The mild Procedure is ideally suited for an ASC setting and we are pleased that CMS has improved the reimbursement for these facilities.
  • We believe this will significantly increase patient access to the mild Procedure across the country," said Philip Macdonald, Vice President, Market Access & Reimbursement for Vertos Medical.
  • Vertos Medical Inc. is a medical device company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS).

Biomechanical Analysis of Inspan Spinous Process Fixation Alone in The Lumbar Spine Demonstrates Positive Results

Retrieved on: 
Tuesday, February 18, 2020
Musculoskeletal system, Medical Subject Headings, Medical classification, Irregular bones, Skeletal system, Vertebrate anatomy, Cervical vertebrae, Vertebra, Lumbar vertebrae, Interspinous ligament, Interspinous process decompression

BOSTON, Feb. 18, 2020 /PRNewswire-PRWeb/ -- INSPAN LLC (a privately-owned company) is pleased to announce the positive results from a biomechanical analysis of spinous process fixation alone or with facet screws in the lumbar spine using the Inspan interspinous fixation device (INSPAN LLC).

Key Points: 
  • BOSTON, Feb. 18, 2020 /PRNewswire-PRWeb/ -- INSPAN LLC (a privately-owned company) is pleased to announce the positive results from a biomechanical analysis of spinous process fixation alone or with facet screws in the lumbar spine using the Inspan interspinous fixation device (INSPAN LLC).
  • Unlike extension block design, the Inspan device fixates the spine to allow for immediate stability, distraction, decompression, and fusion.
  • Biomechanical assessments of interspinous process fixation have demonstrated particularly advantageous outcomes in stabilizing the sagittal plane for during flexion and extension.
  • The Inspan Slim Spinous Process Plate System is a posterior non-pedicle supplemental fixation system intended for use in the non-cervical spine (T1-S1).

Medical Devices Offer a Boost to Viable and Cost-Effective Treatment Options

Retrieved on: 
Thursday, January 30, 2020
Minimally-invasive surgery, Medical terminology, Minimally invasive procedure, Surgery, Interspinous process decompression

For example, a recent increase in demand for minimally invasive surgeries is consequently expected to further energize the market for medical devices suppliers.

Key Points: 
  • For example, a recent increase in demand for minimally invasive surgeries is consequently expected to further energize the market for medical devices suppliers.
  • In addition, devices that would make minimally invasive surgeries more accessible will also aid in controlling healthcare costs.
  • Endonovo Therapeutics, Inc.(OTCQB: ENDV )announced today breaking news that, "sales of SofPulse units to multiple Plastic Surgery Centers.
  • "It is an improvement over traditional spinous process devices because AERIAL expands to fit the interspinous space of the patient's spine.

Medical Devices Offer a Boost to Viable and Cost-Effective Treatment Options

Retrieved on: 
Thursday, January 30, 2020
Minimally-invasive surgery, Medical terminology, Minimally invasive procedure, Surgery, Interspinous process decompression

For example, a recent increase in demand for minimally invasive surgeries is consequently expected to further energize the market for medical devices suppliers.

Key Points: 
  • For example, a recent increase in demand for minimally invasive surgeries is consequently expected to further energize the market for medical devices suppliers.
  • In addition, devices that would make minimally invasive surgeries more accessible will also aid in controlling healthcare costs.
  • Endonovo Therapeutics, Inc.(OTCQB: ENDV )announced today breaking news that, "sales of SofPulse units to multiple Plastic Surgery Centers.
  • "It is an improvement over traditional spinous process devices because AERIAL expands to fit the interspinous space of the patient's spine.

Vertos Medical Appoints New Vice President of Sales

Retrieved on: 
Tuesday, August 6, 2019
Medical specialties, Geriatrics, Spinal cord disorders, Medicine, Branches of biology, Vertos Medical, Lumbar spinal stenosis, LSS, Boston Scientific, Stenosis, Spinal stenosis, Interspinous process decompression

ALISO VIEJO, Calif., Aug. 6, 2019 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), today announced the appointment of Stephen E. Paul as Vice President of Sales.

Key Points: 
  • ALISO VIEJO, Calif., Aug. 6, 2019 /PRNewswire/ -- Vertos Medical Inc., a leader in the development of innovative, minimally invasive treatments for lumbar spinal stenosis (LSS), today announced the appointment of Stephen E. Paul as Vice President of Sales.
  • He has worked for companies such as Boston Scientific, Masimo and most recently served as Vice President of Sales and Commercial Operations for Breg, a major manufacturer and distributor of orthopedic devices.
  • "Steve joins the Vertos leadership team at a pivotal time of growth as we see increased demand for the mildprocedureas a treatment option for millions who suffer from LSS," said Eric Wichems, President and CEO of Vertos Medical.
  • Vertos Medical Inc. is a medical device company committed to developing innovative, minimally invasive treatments for lumbar spinal stenosis (LSS).

Positive Payor Policy Covering coflex® by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis

Retrieved on: 
Friday, February 1, 2019
Surgery, Medicine, Spinal cord disorders, Geriatrics, Neurosurgery, RTT, Spinal stenosis, Lumbar spinal stenosis, Spinal fusion, Laminotomy, Interspinous process decompression, Medical specialties, Medicine, Geriatrics, Spinal cord disorders, Organ systems, Lumbar spinal stenosis, Spinal stenosis, Stenosis, Failed back syndrome, Cervical spinal stenosis

In the news release, Positive Payor Policy Covering coflex by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis, issued Dec. 11, 2018 by Paradigm Spine, LLC over PR Newswire, we are advised by the company that the fourth and fifth paragraphs have been updated to clarify limitations on the coverage policy.

Key Points: 
  • In the news release, Positive Payor Policy Covering coflex by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis, issued Dec. 11, 2018 by Paradigm Spine, LLC over PR Newswire, we are advised by the company that the fourth and fifth paragraphs have been updated to clarify limitations on the coverage policy.
  • The complete, corrected release follows:
    - coflex is a non-fusion, motion-preserving implant for treatment of lumbar spinal stenosis
    - Lumbar spinal stenosis affects 1.6 million U.S. patients annually
    NEW YORK, Dec. 11, 2018 /PRNewswire/ --Paradigm Spine, LLC, a leader in providing solutions for the treatment of lumbar spinal stenosis, today announced that Select Health of South Carolina has issued a clinical policy , dated September 1, 2018, for the exclusive coverage of the coflex interlaminar stabilization device for the treatment of lumbar spinal stenosis under certain specific clinical criteria.
  • The Select Health of South Carolina policy lists several necessary evidence-based criteria and contraindications limiting use of the coflex device.
  • coflex is the only lumbar spinal device that has produced Level I evidence in two separate prospective, randomized, controlled studies against two different control groups, changing the standard of care for lumbar spinal stenosis treatment.

Paradigm Spine Announces Company Activities Highlighting coflex® Interlaminar Stabilization® At NASS Annual Meeting 2018

Retrieved on: 
Monday, September 24, 2018
Medical Subject Headings, Medicine, Surgery, Spinal cord disorders, Geriatrics, Spinal stenosis, Lumbar spinal stenosis, Vertebral column, Spinal fusion, Artificial facet replacement, Interspinous process decompression

NEW YORK, Sept. 24, 2018 /PRNewswire/ -- Paradigm Spine, LLC, a leader in providing motion preservation solutions for the treatment of lumbar spinal stenosis, today announced its Company activities and scientific podium presentation on coflex Interlaminar Stabilization at the upcoming the 2018 North American Spine Society (NASS) Annual Meeting, being held September 26-29 in Los Angeles, Calif. coflex is the only posterior lumbar motion preservation solution with proven long-term outcomes for durable pain relief and stability for patients with moderate to severe spinal stenosis.

Key Points: 
  • NEW YORK, Sept. 24, 2018 /PRNewswire/ -- Paradigm Spine, LLC, a leader in providing motion preservation solutions for the treatment of lumbar spinal stenosis, today announced its Company activities and scientific podium presentation on coflex Interlaminar Stabilization at the upcoming the 2018 North American Spine Society (NASS) Annual Meeting, being held September 26-29 in Los Angeles, Calif. coflex is the only posterior lumbar motion preservation solution with proven long-term outcomes for durable pain relief and stability for patients with moderate to severe spinal stenosis.
  • Historically, the two traditional surgical treatment options for LSS included decompression alone or decompression with lumbar fusion.
  • Paradigm Spine, LLC, founded in 2004, is a privately held company and remains focused on the design and development of solutions for the disease management of spinal stenosis.
  • The Company's signature product is the coflex Interlaminar Stabilization device, which is currently used in over 60 countries worldwide.